Document is current

Any future updates will be listed below

A retrospective study of azacitidine treatment in patients with intermediate-2 or high risk myelodysplastic syndromes in a real-world clinical setting in Greece

Crossref DOI link: https://doi.org/10.1007/s12185-016-2115-y

Published Online: 2016-11-04

Published Print: 2017-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark